Pathway Therapeutics
San Francisco · Founded 2008
About Pathway Therapeutics
Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.
Company Facts
- Founded: 2008
- Legal name: Pathway Therapeutics Ltd.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.4M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Mar 2013)
- Website: pathwaytx.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/pathway-therapeutics-8420102 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.